Role of Microbiome in the Realm of Immune-Checkpoint Inhibitor Induced GI Complications In Cancer Population

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03819296

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:15.195646+00:00

Published At

2026-03-11T00:00:00+00:00

Record Updated At

2026-03-11

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Clinical Stage 0 Cutaneous Melanoma AJCC v8", "Clinical Stage I Cutaneous Melanoma AJCC v8", "Clinical Stage IA Cutaneous Melanoma AJCC v8", "Clinical Stage IB Cutaneous Melanoma AJCC v8", "Clinical Stage II Cutaneous Melanoma AJCC v8", "Clinical Stage IIA Cutaneous Melanoma AJCC v8", "Clinical Stage IIB Cutaneous Melanoma AJCC v8", "Clinical Stage IIC Cutaneous Melanoma AJCC v8", "Clinical Stage III Cutaneous Melanoma AJCC v8", "Clinical Stage IV Cutaneous Melanoma AJCC v8", "Colitis", "Lung Non-Small Cell Carcinoma", "Malignant Genitourinary System Neoplasm", "Malignant Solid Neoplasm", "Pathologic Stage 0 Cutaneous Melanoma AJCC v8", "Pathologic Stage I Cutaneous Melanoma AJCC v8", "Pathologic Stage IA Cutaneous Melanoma AJCC v8", "Pathologic Stage IB Cutaneous Melanoma AJCC v8", "Pathologic Stage II Cutaneous Melanoma AJCC v8", "Pathologic Stage IIA Cutaneous Melanoma AJCC v8", "Pathologic Stage IIB Cutaneous Melanoma AJCC v8", "Pathologic Stage IIC Cutaneous Melanoma AJCC v8", "Pathologic Stage III Cutaneous Melanoma AJCC v8", "Pathologic Stage IIIA Cutaneous Melanoma AJCC v8", "Pathologic Stage IIIB Cutaneous Melanoma AJCC v8", "Pathologic Stage IIIC Cutaneous Melanoma AJCC v8", "Pathologic Stage IIID Cutaneous Melanoma AJCC v8", "Pathologic Stage IV Cutaneous Melanoma AJCC v8", "Stage 0 Lung Cancer AJCC v8", "Stage I Lung Cancer AJCC v8", "Stage IA1 Lung Cancer AJCC v8", "Stage IA2 Lung Cancer AJCC v8", "Stage IA3 Lung Cancer AJCC v8", "Stage IB Lung Cancer AJCC v8", "Stage II Lung Cancer AJCC v8", "Stage IIA Lung Cancer AJCC v8", "Stage IIB Lung Cancer AJCC v8", "Stage III Lung Cancer AJCC v8", "Stage IIIA Lung Cancer AJCC v8", "Stage IIIB Lung Cancer AJCC v8", "Stage IIIC Lung Cancer AJCC v8", "Stage IV Lung Cancer AJCC v8", "Stage IVA Lung Cancer AJCC v8", "Stage IVB Lung Cancer AJCC v8"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-03-11"

protocolSection.identificationModule.nctId

"NCT03819296"

protocolSection.identificationModule.officialTitle

"Role of Microbiome in the Realm of Immune-Checkpoint Inhibitor Induced GI Complications In Cancer Population"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Clinical Stage 0 Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage I Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage IA Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage IB Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage II Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage IIA Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage IIB Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage IIC Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage III Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage IV Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Colitis (protocolSection.conditionsModule.conditions)
• Lung Non-Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Malignant Genitourinary System Neoplasm (protocolSection.conditionsModule.conditions)
• Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
• Pathologic Stage 0 Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage I Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IA Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IB Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage II Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIA Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIB Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIC Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage III Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIID Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IV Cutaneous Melanoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage 0 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage I Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IA1 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IA2 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IA3 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage II Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIC Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IV Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.